# Lcr35 / ICU / P. Aeruginosa

> **NCT00621803** · NA · TERMINATED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 400 (actual)

## Conditions studied

- Pseudomonas Infections

## Interventions

- **DRUG:** Probiotic Lactobacillus casei rhamnosus (Lcr35)

## Key facts

- **NCT ID:** NCT00621803
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-03
- **Primary completion:** 2004-10
- **Final completion:** 2005-10
- **Target enrollment:** 400 (ACTUAL)
- **Why stopped:** Recruiting or enrolling participants has halted and will not resume
- **Last updated:** 2008-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621803, "Lcr35 / ICU / P. Aeruginosa". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00621803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*